Search Results - "Madu, Aj"

Pattern of blood donation and characteristics of blood donors in Enugu, Southeast Nigeria by Ugwu, A, Madu, A, Efobi, C, Ibegbulam, O

“…Background: Despite increasing need for blood donation in medical practice, little is known about pattern of blood donation and characteristics of blood donors…”
Get full text

Challenges in the management of bleeding disorders in Nigeria by Okoye, H, Korubo, K, Nwogoh, B, Efobi, C, Ugwu, N, Madu, A

“…Background: Bleeding disorders (BDs) are characterized by abnormal bleeding for which effective management requires a combination of skill, workforce,…”
Get full text

Utilization of oral anticoagulation in a teaching hospital in Nigeria by Anakwue, Rc, Ocheni, S, Madu, Aj

“…Anticoagulation is an essential lifesaving management practice indicated for arterial, venous and intracardiac thromboembolism. This study was undertaken to…”
Get full text

Rates and determinants of peripartum and puerperal anemia in Enugu, Nigeria by Emegoakor, C, Iyoke, C, Ezegwui, H, Umeora, O, Lawani, L, Madu, A

“…Background: Anemia in the peripartum or postpartum period could pose a significant risk for maternal morbidity and mortality during and after delivery. Aims:…”
Get full text

Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria by Madu, A, Okoye, A, Ajuba, I, Madu, K, Anigbo, C, Agu, K

“…Aim: To assess the prevalence and associations of symptomatic renal papillary necrosis (RPN) in sickle cell anemia patients. Patients and Methods: The case…”
Get full text

Important clinical and laboratory correlates of glomerular filtration rate in sickle cell anemia by Madu, A J, Ubesie, A, Ocheni, S, Chinawa, J, Madu, K A, Ibegbulam, O G, Nlemadim, C, Eze, A

“…Renal impairment is routinely assessed using the estimated glomerular filtration rate (eGFR) and it may be helpful to obtain certain clinical or laboratory…”
Get full text

Multiple myeloma in Nigeria: an insight to the clinical, laboratory features, and outcomes by Madu, A J, Ocheni, S, Nwagha, T A, Ibegbulam, O G, Anike, U S

“…In developing African nations, late presentation and occurrence of complications adversely affects survival. This study aims at identifying initial clinical…”
Get full text

Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study by Jude, Madu Anazoeze, Aliyua, Galadanci Najiba, Nalado, Aisha Mohammed, Garba, Kangiwa Umar, Florence, O Florence, Hassan, Ahmed, Inyama, Marcus, Akinpelu, Oluwaseun, Theresa, Nwagha, Sunday, Ocheni, Ifeoma, Embodi, Anthony, Ikefuna, Batholomew, Chukwu, Chide, Okocha E, Orkuma, Joseph, Malachy, Iheanacho, Korubo, Kaladada, Sabastine, Anike Uchenna, Kingsley, Agu, Nonyelu, Charles, Ugwu, Angela, Duru, Augustine, Anigbo, Chukwudi, Eze, Alozie, Chukwurah, Awele, Ololo, Uchenna, Omoti, Caroline, Agwu, Obinneche, Iheanyi, Okpala

“…: Background: Stroke is a life-changing, debilitating complication of sickle cell disease (SCD). Previous studies had recorded high stroke prevalence amongst…”
Get full text

Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation by Ajuba, I C, Madu, A J, Okocha, C, Ibegbulam, O G, Okpala, I, Nna, O E

“…Variations in disease presentation and outcome of leukemia treatment has been associated with the presence of certain mutant genes. Three major translocations…”
Get full text

Medical Specialist Preferences and Reasons among Fresh Nigerian Interns by Madu, Aj, Ubesie, A, Madu, Ka, Nonyelu, C, Ibegbulam, Og

“…Developing countries like face dire shortage of medical manpower due to brain drain. Young doctors intending to specialize usually prefer certain specialties…”
Get full text

Avascular necrosis in sickle cell (homozygous S) patients: predictive clinical and laboratory indices by Madu, A J, Madu, A K, Umar, G K, Ibekwe, K, Duru, A, Ugwu, A O

“…Pathogenetic mechanism as well as laboratory and clinical correlates of osteonecrosis in sickle cell have not been fully investigated. The aim of this study is…”
Get full text

Pattern of CD4 T-lymphocyte values in Cancer patients on cytotoxic therapy by Madu, A, Ocheni, S, Ibegbulam, O, Aguwa, E, Madu, K

“…Background: Assessment of patients prior to cytotoxic chemotherapy usually includes absolute neutrophils count. Other cellular markers of susceptibility to…”
Get full text

Bortezomib Prescription Pattern for the Treatment of Multiple Myeloma by Hematologists in Nigeria by Korubo, Kaladada I, Madu, Anazoeze J, Okoye, Helen C, Nwogoh, Benedict

“…Novel therapy has dramatically changed the outcome of patients with myeloma. Current National Comprehensive Cancer Network guidelines give bortezomib-based…”
Get full text